The good news is:
"To support Next Science’s commercial strategy, we will be reporting the first sets of
retrospective patient case series in joint replacement (400 & 500 patients
respectively) at the end of Q2. Encouragingly, early indications suggest there are
zero infections amongst the nine hundred patients."
The good news is:"To support Next Science’s commercial strategy,...
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.020(6.06%) |
Mkt cap ! $102.0M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 35.0¢ | 32.0¢ | $72.71K | 212.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 20605 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 25000 | 1 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
35.0¢ |
Change
0.020 ( 9.38 %) |
||||
| Open | High | Low | Volume | ||
| 33.0¢ | 35.0¢ | 32.0¢ | 46548 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| NXS (ASX) Chart |